OptiNose, Inc. Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020
Revenues
Net product revenues
Licensing revenues
Total revenues
Costs and expenses:
Cost of product sales
Research and development
Selling, general and administrative
Total costs and expenses
Loss from operations
Other (income) expense:
Unrealized (gain) loss on fair value of warrants
Other income
Interest income
Foreign currency (gains) losses
Loss on extinguishment of debt
Interest expense

Net loss
Net loss per share of common stock, basic and diluted (in dollars per share)
Weighted average common shares outstanding, basic and diluted (in shares)
Net loss per share of common stock, basic (in dollars per share)
Net loss per share of common stock, diluted (in dollars per share)
Weighted average common shares outstanding, basic (in shares)
Weighted average common shares outstanding, diluted (in shares)

Comments